|
Re: New Share Price Contest
|
6
|
Resverlogix Corp.
|
Oct 11, 2019 02:45AM
|
|
Re: Spike
|
6
|
Resverlogix Corp.
|
Sep 09, 2018 01:36PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 22, 2022 01:44PM
|
|
Re: CANTOS and CIRT
|
6
|
Resverlogix Corp.
|
Nov 13, 2017 04:26PM
|
|
Re: BETonMACE top line data
|
6
|
Resverlogix Corp.
|
Jan 16, 2018 12:58AM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 01:14PM
|
|
Re: pfizer
|
6
|
Resverlogix Corp.
|
Dec 16, 2020 01:44PM
|
|
Re: What is Mr. Market saying about RVX?
|
6
|
Resverlogix Corp.
|
Nov 26, 2018 11:39AM
|
|
Re: This late June meeting, warrants about to expire???
|
6
|
Resverlogix Corp.
|
Apr 12, 2021 01:36PM
|
|
Re: Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink
|
6
|
Resverlogix Corp.
|
Dec 04, 2017 11:34AM
|
|
Re: New Frontiers for both RVX/Zenith
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 06:22PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Jan 16, 2018 09:22AM
|
|
Re: Bear
|
6
|
Zenith Epigenetics
|
Apr 22, 2020 01:43PM
|
|
Re: AEGIS-II trial
|
6
|
Resverlogix Corp.
|
Mar 22, 2018 12:35PM
|
|
Re: RSU's awarded
|
6
|
Resverlogix Corp.
|
Sep 19, 2019 08:25PM
|
|
Re: A couple of recent RVX-208 articles related to selective bromodomain inhibition
|
6
|
Resverlogix Corp.
|
Sep 13, 2017 08:29PM
|
|
Re: More than "Material"
|
6
|
Resverlogix Corp.
|
Mar 16, 2021 01:25AM
|
|
Re: Dialysis patients and RVX-208
|
6
|
Resverlogix Corp.
|
Mar 13, 2019 10:31AM
|
|
Re: Naz listing?
|
6
|
Resverlogix Corp.
|
Apr 19, 2019 01:51PM
|
|
Re: BMO Current Value at 0
|
6
|
Zenith Epigenetics
|
Oct 31, 2018 12:12PM
|
